Associations between serum amino acids and genetic liability to depression in the LURIC cohort - Report - MDSpire

Links Between Serum Amino Acid Levels and Genetic Predisposition to Depression in the LURIC Study

  • By

  • Robert M. Krämer

  • Graciela E. Delgado

  • Marcus E. Kleber

  • Daniel Duerschmied

  • Winfried März

  • Angela Patricia Moissl-Blanke

  • July 17, 2026

Share

Links Between Serum Amino Acid Levels and Genetic Predisposition to Depression in the LURIC Study

Overview

This study investigates the relationship between genetic predisposition to depression and serum amino acid concentrations in a cohort from the LURIC study.

Background

Major depression is a prevalent psychiatric disorder with significant global health implications. This study explores the potential role of serum amino acids as biomarkers linked to genetic risk for depression.

Data Highlights

No specific numerical data or trial results were provided in the source material.

Key Findings

  • Major depression affects approximately 7.5% of men and 13.6% of women worldwide.
  • Genetic depression risk scores (GDRS) have been associated with all-cause and cardiovascular mortality.
  • Circulating amino acids are proposed as biomarkers due to their roles in neurotransmission and metabolic regulation.
  • Previous studies have shown inconsistent findings regarding amino acid concentrations in major depression.
  • Alterations in amino acid metabolism may be linked to depression, particularly in glutamatergic signaling and the tryptophan–kynurenine pathway.

Clinical Implications

Understanding the associations between serum amino acids and genetic predisposition to depression may aid in identifying potential biomarkers for mood disorders.

Conclusion

The study highlights the potential link between genetic risk for depression and serum amino acid levels.

Related Resources & Content

  1. Frontiers in Psychiatry, 2026 -- Genetic variation associated with depression in Latin American populations: a systematic review of single-nucleotide variants
  2. BMC Psychiatry (Springer), 2026 -- Exploring the Genetic Connections and Treatment Opportunities Between Major Depressive Disorder and Metabolic Syndrome: Insights from Multi-Ancestry and Multi-Trait Genome-Wide Association Studies
  3. Frontiers in Immunology, 2026 -- Serum inflammatory cytokines in the progression of depression
  4. Overview | Depression in adults: treatment and management | Guidance | NICE, 2026
  5. Frontiers in Psychiatry — Exploring the Relationship Between Depression and Diabetes in Women: Insights on Interleukin-4 and Inflammatory Biomarkers Based on Measurement Variability
  6. Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies
  7. Characterizing metabolomic and proteomic changes in depression: a systematic analysis
  8. Overview | Depression in adults: treatment and management | Guidance | NICE

Original Source(s)

Related Content